SynDermix identifies and acquires the rights to innovative products, which it develops until a robust demonstration of their clinical value and then drives their commercialisation through corporate partnerships.

Cooperation possibilities

We are interested in partnerships for the further development of the products in our portfolio and/or their commercialisation.

Location
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2009
  • Number of employees in Switzerland
    1-9